Condition: Gastrointestinal Neoplasms · Benign Neoplasm of Intestinal Tract · Sponsor: California Pacific Medical Center Research Institute
To evaluate clinical outcome for patients receiving treatment of suspected premalignant and malignant gastrointestinal lesions at Interventional Endoscopy Services. The primary outcome is curative endoscopic resection. Secondary outcomes include resection technique utilized, rates of en bloc resection and adverse event rates, including infection, bleeding, perforation and death, and one-year survival rates.
This description comes directly from the study's public registry record.
Jona C Bernabe · 415-600-1151 · jona.bernabe@sutterhealth.org
Hayden Sampson · 415-600-1151 · Hayden.sampson@sutterhealth.org
Always discuss trial participation with your own doctor first.
| Interventional Endoscopy Services | San Francisco, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01750619